Connected Drug Delivery Devices Market Overview

The market research analysis forecasts significant growth within the Connected Drug Delivery Devices Market. This comprehensive report meticulously outlines the drivers fueling this growth, key restraints, forthcoming challenges, and abundant opportunities present in the global Connected Drug Delivery Devices market landscape. The report delves into a detailed regional and segmental breakdown, providing a comprehensive understanding of the market's dynamics and size.

For detail insights on this market, request for methodology here @ :

Market Values: 

Connected Drug Delivery Devices Market size was valued at USD 1219.93 Mn. in 2022 and the total Connected Drug Delivery Devices revenue is expected to grow at a CAGR of 36.10% from 2023 to 2029, reaching nearly USD 10552.30 Mn.

Market Report Scope and Research Methodology

Research Methodology:

This research employs a meticulous approach to examining the most influential trends shaping the Connected Drug Delivery Devices market and their potential impacts on new business investments and industry expansion. The study extensively analyzes market trends, encompassing new technologies, regulatory landscapes, government investments, emerging applications, international market entry strategies, and other industry dynamics. Its primary objective is to equip clients with an in-depth understanding of these trends, enabling the development of robust strategies to fortify their presence in the Connected Drug Delivery Devices market.

Report Scope:

The report's scope is extensive, aiming to provide a comprehensive view of the industry landscape. It meticulously delineates the drivers catalyzing market growth, highlights obstacles that may impede progress, identifies potential challenges, and uncovers lucrative opportunities within the Connected Drug Delivery Devices market. Additionally, the report offers a granular breakdown, analyzing market dynamics and size across various regions and segments.

Market dynamics for Connected Drug Delivery Devices:

A High Rate of Chronic Illnesses

 Globally, the incidence of chronic conditions including diabetes, COPD, and asthma is on the rise, which presents enormous potential for the connected drug delivery devices market to flourish. For example, a study on diabetes prevalence predictions for 2021 released in January 2022 by the National Library of Medicine and National Centre for Biotechnology Information indicated that 10.5% of people aged 20 to 79 had diabetes in 2021 and that number might increase to 12.2% by 2045. Diabetes is predicted to affect both men and women equally, with people 75 to 79 years old having the highest prevalence.

Market Segmentation:

by Product
Connected Sensors
Integrated Connected Devices

With the biggest share of over 64% in the Connected Drug Delivery Devices market in 2021, the Connected Sensors segment led the market based on product and is anticipated to expand at a CAGR of 35.5% over the course of the forecast period. In fact, if the device is disposable, attached sensors can be reused in conjunction with current delivery systems without causing any disruption to their normal functioning. These sensors are subdivided into linked inhaler sensors and connectable injectable sensors.

by End-User
Healthcare Providers
Homecare Centres

In 2021, the Connected Drug Delivery Devices market was dominated by the Healthcare Providers sector, which had the greatest market share among End-users. Over the course of the projection period, the category is anticipated to continue to dominate with the highest CAGR of over 32.8%. Adequate patient health record-keeping is necessary due to the increased prevalence of chronic diseases such as diabetes, cardiovascular conditions (CVDs), and lung cancer. Connected drug delivery systems store health data in addition to tracking medication delivery and use. The goal of clinicians is to treat as many patients as possible with the greatest potential health outcomes. For the benefit of the patient, they want to ensure adherence, and they are thinking about using linked devices to do so.

Key Players in the Connected Drug Delivery Devices Market Include:

1. Propeller Health (US)
2. West Pharmaceutical Services, Inc. (US)
3. 3M Company (US)
5. BD Medical - Pharmaceutical Systems (US)
6. Antares Pharma, Inc. (US)
7. Johnson & Johnson Services, Inc. (US)
8. CeQur Corporation (US)
9. SMC Ltd. (US)
10.Philips Medisize (US)
11.ViVO Smart Medical Devices Ltd. (UK)
12.Sagentia (UK)
13.Bayer AG (Germany)
14.Gerresheimer AG (Germany)
15.Merck Group (Germany)
16.Biocorp Production SA (France)
17.Sanofi (France)
18.Novartis AG (Switzerland)
19.Sulzer Ltd. (Switzerland)
20.MEDMIX SYSTEMS AG. (Switzerland)
21.Novosanis NV (Belgium)
22.FindAir (Poland)
23.Adherium Lmited (New Zealand)

To Gain A Better Understanding, Request Sample Now:

Regional Insights:

The report includes a detailed analysis of various regions and their respective countries, including:

  1. Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)
  2. Europe (Turkey, Germany, Russia, UK, Italy, France, etc.)
  3. North America (the United States, Mexico, and Canada)
  4. South America (Brazil, etc.)
  5. The Middle East and Africa (GCC Countries and Egypt) 

Table of Content: Connected Drug Delivery Devices Market

 Part 01: Executive Summary

Part 02: Scope of the Connected Drug Delivery Devices Market Report

Part 03: Global Connected Drug Delivery Devices Market Landscape

Part 04: Global Connected Drug Delivery Devices Market Sizing

Part 05: Global Connected Drug Delivery Devices Market Segmentation by Type

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers and Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

For additional resources and details on this research, check out:

Key Questions answered in the Connected Drug Delivery Devices Market Report are:

  • What is Connected Drug Delivery Devices ?
  • What is the expected CAGR of the Connected Drug Delivery Devices market during the forecast period?
  • What is the expected Connected Drug Delivery Devices market size by 2029?
  • What factors are affecting the Connected Drug Delivery Devices market growth?
  • Which region held the largest share of the global Connected Drug Delivery Devices market?
  • What growth strategies are the players considering to increase their presence in Connected Drug Delivery Devices ?
  • Who are the leading players in Connected Drug Delivery Devices Market?

Key Offerings:

  • A detailed Analysis of the Market Overview
  • Market Share, Size & Forecast by Revenue | 2023−2029
  • Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Key Trends
  • Market Segmentation – A detailed analysis by Route of administration, Application, Facility of use and Region and Region
  • Competitive Landscape – Top Key Vendors and Other Prominent Vendors

About Maximize Market Research:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

Contact Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2

Pune Banglore Highway, Narhe,

Pune, Maharashtra 411041, India

+91 96071 95908, +91 9607365656